cp-945598 Search Results


90
Bio-Techne corporation il 1β
Il 1β, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/CP+945598+hydrochloride/10__4236_slash_jcdsa__2022__122009-47-12-37
Average 90 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
MedChemExpress otenabant
Effect of 3-arm antagonists in modulating GRAB eCB2.0 fluorescence in presence of 300 nM CP55940.
Otenabant, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/Otenabant/pmc11084632-210-32-33
Average 94 stars, based on 1 article reviews
otenabant - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Tocris drug cp945598 hydrochloride tocris
Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist <t>CP945598,</t> orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page
Drug Cp945598 Hydrochloride Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/CP+945598+hydrochloride/10__7554_slash_elife__33892-280-64-67
Average 93 stars, based on 1 article reviews
drug cp945598 hydrochloride tocris - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Pfizer Inc cp-945598
Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist <t>CP945598,</t> orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page
Cp 945598, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/cp+945598/us08546394-669-22-25
Average 90 stars, based on 1 article reviews
cp-945598 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cp-945598
Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist <t>CP945598,</t> orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page
Cp 945598, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/cp+945598/pmc10500295-25-0-4
Average 90 stars, based on 1 article reviews
cp-945598 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ApexBio cp945598
Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist <t>CP945598,</t> orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page
Cp945598, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/cp945598/ppr0475905-79-8-9
Average 90 stars, based on 1 article reviews
cp945598 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
TargetMol otenabant
Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist <t>CP945598,</t> orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page
Otenabant, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cp-945598/Otenabant/pm36709687-52-31-32
Average 91 stars, based on 1 article reviews
otenabant - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier


N/A
Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. Phase 1.
  Buy from Supplier

N/A
Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. Phase 1.
  Buy from Supplier

N/A
Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptorA selective and high affinity CB1 antagonist.
  Buy from Supplier

N/A
Otenabant(Cat No.:I004580)is an experimental drug that acts as a selective inverse agonist of the cannabinoid receptor CB1. CB1 receptors are involved in regulating appetite, mood, and metabolic processes, and their activation has been linked to
  Buy from Supplier

Image Search Results


Effect of 3-arm antagonists in modulating GRAB eCB2.0 fluorescence in presence of 300 nM CP55940.

Journal: International Journal of Molecular Sciences

Article Title: Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB eCB2.0 Sensor

doi: 10.3390/ijms25095012

Figure Lengend Snippet: Effect of 3-arm antagonists in modulating GRAB eCB2.0 fluorescence in presence of 300 nM CP55940.

Article Snippet: Chemicals and Reagents: 2-AG (Cayman, Ann Arbor, MI, USA #62160), CP55940 (Cayman #13608), ACEA (Biotechne, Minneapolis, MN, USA: Tocris #1319), SR141716 (MedChem Express, New York, NY, USA: #HY14136), Taranabant (MedChem Express #HY10013), Otenabant (MedChem Express #HY-10871), Ibipinabant (MedChem Express HY-14791), and GAT228 and GAT229 (MilliporeSigma: Burlington, MA, USA #SML1952 and #SML1951).

Techniques: Fluorescence

Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist CP945598, orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page

Journal: eLife

Article Title: Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons

doi: 10.7554/elife.33892

Figure Lengend Snippet: Figure 3. Retrograde endocannabinoid signaling underlies oxytocinergic modulation of excitatory synaptic transmission. (A) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 5 mM CB1R agonist WIN55212-2 application. Right: summary data for EPSC amplitude over time, normalized to baseline. (B) Left: example traces of evoked EPSCs from one VTA DA neuron during baseline and following 1 mM oxytocin application in the presence of CB1R agonist WIN55212-2. Right: summary data for EPSC amplitude over time, normalized to baseline. (C) Same as (B), but in the presence of CB1R inverse agonist AM251. (D) Same as (B), but in the presence of orlistat (THL), a blocker of 2-AG synthesizing enzyme diacylglycerol lipase a (DGLa). (E) Same as (B), but with THL in the internal solution to block 2-AG synthesis. (F) Same as (B), but with U73122 in the internal solution to inhibit PLC activity. (G) Summary data for EPSC amplitude changes induced by CB1R agonist WIN55212-2 and oxytocin in the presence of WIN55212-2, CB1R inverse agonist AM251, CB1R antagonist CP945598, orlistat (THL), intracellular THL, and intracellular U73122, separately. **p<0.01, Wilcoxon signed rank Figure 3 continued on next page

Article Snippet: DOI: https://doi.org/10.7554/eLife.33892 17 of 26 Continued Reagent type (species) or resource Designation Source or reference Identifiers Additional information chemical compound, drug SR 49059 Tocris Cat#2310; CAS 150375-75-0 chemical compound, drug NBQX disodium salt Tocris Cat#1044; CAS 479347-86-9 chemical compound, drug (RS)-CPP Tocris Cat#0173; CAS 100828-16-8 chemical compound, drug SR95531 hydrobromide Tocris Cat#1262; CAS 104104-50-9 chemical compound, drug U73122 Tocris Cat#1268; CAS 112648-68-7 chemical compound, drug CP945598 hydrochloride Tocris Cat#4236; CAS 686347-12-6 chemical compound, drug WIN55212-2 Tocris Cat#1038; CAS 131543-23-2 chemical compound, drug AM251 Tocris Cat#1117; CAS 183232-66-8 chemical compound, drug orlistat (THL) Tocris Cat#3540; CAS 96829-58-2 chemical compound, drug MNI-L-glutamate Tocris Cat#1490; CAS 295325-62-1 chemical compound, drug Alexa Fluor 488 hydrazide Thermo Fisher Scientific Cat#A10436 chemical compound, drug Alexa Fluor 594 hydrazide Thermo Fisher Scientific Cat#A10438 chemical compound, drug Green retrobeads (GRB) Lumafluor Inc. Cat#G180 software, algorithm GraphPad Prizm 5 GraphPad RRID:SCR_002798 software, algorithm FIJI Schindelin et al., 2012 http://fiji.sc/; RRID:SCR_002285 software, algorithm MATLAB MathWorks RRID:SCR_001622 software, algorithm Igor Pro Wavemetrics RRID:SCR_000325 software, algorithm SPSS IBM RRID:SCR_002865

Techniques: Transmission Assay, Blocking Assay, Activity Assay